PropThink: Potential FDA Warning and Earnings Overshadow STJ Share Repurchase Program

[ACN Newswire] – By Jake KingShares of St. Jude Medical (NYSE:STJ) opened 6% lower Wednesday morning following the company’s quarterly report and conference call, which included discussion of a potential FDA warning letter … more

View todays social media effects on STJ

View the latest stocks trending across Twitter. Click to view dashboard